Very methodical and independent Peer review that ties up some historical loose ends and validates potential of biomarker study. "Fast Track" Innovation Passport in the UK, oversubscribed Capital Raise, Depression trial results likely July, early August and the thesis again gets tested as to whether a safe reduction in Cortisol, improves cognition. Long way to go, but you have to admire the way they are going about it that makes other Biotechs look like amateurs.
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis, page-11
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
